Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2298131
Max Phase: Preclinical
Molecular Formula: C21H12Cl3NO
Molecular Weight: 400.69
Molecule Type: Small molecule
Associated Items:
ID: ALA2298131
Max Phase: Preclinical
Molecular Formula: C21H12Cl3NO
Molecular Weight: 400.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1/C(=C\c2ccccc2Cl)c2ccccc2N1c1c(Cl)cccc1Cl
Standard InChI: InChI=1S/C21H12Cl3NO/c22-16-8-3-1-6-13(16)12-15-14-7-2-4-11-19(14)25(21(15)26)20-17(23)9-5-10-18(20)24/h1-12H/b15-12-
Standard InChI Key: IMDOTPAZGALFAU-QINSGFPZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 400.69 | Molecular Weight (Monoisotopic): 398.9984 | AlogP: 6.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.60 | CX LogD: 6.60 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.43 | Np Likeness Score: -0.94 |
1. Manvar A, Bavishi A, Loriya R, Jaggi M, Shah A. (2013) In vitro cytotoxicity evaluation of diversely substituted N-aryl-2-oxindoles, 22 (7): [10.1007/s00044-012-0309-2] |
Source(1):